Methyl-n-amylnitrosamine
Appearance
![]() | |
Names | |
---|---|
Preferred IUPAC name
N-Methyl-N-pentylnitrous amide | |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
MeSH | N-amyl-N-methylnitrosamine |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H14N2O | |
Molar mass | 130.191 g·mol−1 |
Appearance | Yellow, transparent liquid |
log P | 1.542 |
Related compounds | |
Related amines
|
|
Related compounds
|
Agmatine |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Methyl-n-amylnitrosamine (MNAN) is a potential carcinogen[1] It is metabolized in the liver by the enzyme CYP2A6.
References
- ^ Bulay O, Mirvish SS (September 1979). "Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine". Cancer Res. 39 (9): 3644–6. PMID 476689.